|Description||Varenicline(CP 526555; Champix; Chantix) is a prescription medication used to treat smoking addiction. As a partial agonist it both reduces cravings for and decreases the pleasurable effects of cigarettes and other tobacco products. Through these mechanisms Varenicline(CP 526555; Champix; Chantix) can assist some patients to quit smoking.|
|B0084-064059||1 g||$499||In stock|
|Synonyms||CP 526555; Champix; Chantix; CP526555; CP-526555|
NS 6784 hydrochloride is an α7 nAChR agonist at human with EC50 value of 0.72 μM.
EVP-6124 is a novel partial agonist of α7 neuronal nicotinic acetylcholine receptors (nAChRs). It shows selectivity for α7 nAChRs and did not activate or inhibi...
TC 1698 dihydrochloride
TC 1698 dihydrochloride is a selective nicotinic α7 receptor agonist (EC50 = 440 nM) displaying neuroprotective activity. TC 1698 dihydrochloride also displays ...
TC 2559 difumarate
TC 2559 difumarate is a subtype-selective partial agonist for α4β2 nicotinic acetylcholine receptors (EC50 = 0.18, 12.5, 14.0, > 30, > 100 and > 100 μM for α4β2...
Sofinicline is a novel nicotinic acetylcholine receptor agonist under development of Abbott Laboratories. Till now, no development was reported for Phase-II for...
CP-601932 is a CNS-penetrant, high affinity, and selective α(4) β(2) nicotinic acetylcholine receptors partial agonist.
Bradanicline hydrochloride is Alpha-7 Nicotinic Receptor Agonist. It showed cognitive enhancing effects in animal studies, and was being developed as a potentia...
α-Conotoxin AuIB is a selective antagonist of α3β4 nicotinic acetylcholine receptors. It shows > 100-fold selectivity over other receptor subunit combinations.